Por: The Boston Globe Business July 26, 2024
Eli Lilly & Co. is down more than $120 billion in market value and its status as the poster child of the weight-loss drug frenzy is under threat with at least two rivals posting encouraging developments for their obesity treatments.The company’s shares fell as much as 6.2 percent on Thursday, hitting the lowest intraday level since May. They’re down 14 percent over the past eight trading sessions, their worst eight-day stretch since 2020.New... + full article
WPTV USA Nation February 01, 2024
Health care advocates introduced what they call the first-ever with the hopes of changing workplace policies and state and federal laws. The Obesity Bill of Rights, which was published Wednesday by the National Consumers League and National Council on Aging, has the backing... + más
Did Martha Washington really name a cat after Alexander Hamilton? | The Boston Globe
'Frustration' fuels Broncos' sideline blowup in loss | ESPN
Fox Business USA Business January 04, 2024
Beachbody co-founder and CEO Carl Daikeler explains how the popularity of weight loss drugs is impacting online fitness subscriptions on 'The Claman Countdown.' became the latest in a growing number of companies making it even easier for patients to gain access to... + más
FDA approves a new weight loss drug, Zepbound from Eli Lilly | CBS News
As Eli Lilly Gears Up For Growth, Its CFO Prescribes Leading Indicators | Forbes
MarketWatch USA Business December 23, 2023
Key clinical-trial data emerging over the next year “will really start to dictate who will be the competitors against Lilly and Novo,” said Damien Conover, director of healthcare research at Morningstar. While new, next-generation obesity drugs aren’t likely to hit the... + más
NFL Playoff Scenarios | ABC News
Eli Lilly, Novo Nordisk test popular weight loss-related drugs on children | Fox Business
WPTV USA Nation March 04, 2023
The global economic impact of obesity in 2035 is expected to be comparable to that of COVID-19 in 2020, according to a new report by the World Obesity Federation. half of the world’s population will either be considered overweight or obese by 2035. Even more concerning,... + más
Half Of Global Population Will Be Overweight In 12 Years: Study | RTTNews
‘Worrying’ global obesity projections for 2035 revealed in new report | New York Post
RTTNews USA Health March 03, 2023
More than half the global population will be living with overweight and obesity within 12 years if prevention, treatment and support do not improve, says a global study conducted by the World Obesity Federation.The World Obesity Atlas 2023, published ahead of World Obesity Day,... + más
World’s fattest countries revealed: Where does America fall on the list? | New York Post
Forbes USA Tech January 25, 2023
Since its launch in 2021, Novo Nordisk’s weight loss drug, Wegovy, set the stage for the next ... [+] generation of anti-obesity drugs. Now a new drug on the scene promises to be more effective and safer than any other weight loss drug before.getty Obesity remains one of the... + más
New guidance: Use drugs, surgery early for obesity in kids | ABC News
Use drugs and surgery early for obesity in kids, new guidance says | Orlando Sentinel
Forbes USA Business December 15, 2022
Along the corridors of Indianapolis-based Eli Lilly, NBP may not have the brand swagger of Trulicity or Mounjaro, but as the drugmaker eyes a rich menu of growth opportunities, the sturdy acronym promises to be a powerful pain reliever. Or so Lilly CFO Anat Ashkenazi explains,... + más
Twitter was once a necessity for major brands. Under Elon Musk, it's now high risk. | CBS News
A fake tweet sparked panic at Eli Lilly and may have cost Twitter millions | Portland Press Herald
About iurex | Privacy Policy | Disclaimer |